The hypothesis of a neurodevelopmental dysfunction being involved in the etiology of schizophrenia is suggested by the observation of morphological alterations in the brains of schizophrenia patients. These alterations may be caused by defects in neural cell differentiation or migration, which could lead to disrupted neuronal circuitry and to the schizophrenia symptomatology. The neural cell adhesion molecule (NCAM) plays a major role in cell migration and axon outgrowth, and is involved in synaptic plasticity mechanisms implicated in adult cognitive functions. Altered levels of the NCAM polysialylated form, PSA-NCAM, in the brain of schizophrenia patients have been reported, and are supportive of a role for this molecule in the disorder. To investigate the possible involvement of the NCAM gene in schizophrenia, we conducted a comprehensive genetic study, which included linkage analysis and an association study employing the Haplotype Relative Risk (HRR) design in nuclear families. Our results indicate that structural alterations in the NCAM gene are unlikely to play a major role in schizophrenia, although a function for the NCAM molecule in the etiology of the disease remains an intriguing hypothesis.
The neurodevelopmental hypothesis of schizophrenia in morphogenesis, cell differentiation and cell migration (for a review see Cunningham
12
). NCAM is is suggested by the observation of morphological abnormalities of developmental origin in a subset of encoded by a single gene that undergoes alternative splicing to generate multiple different variants, with schizophrenia patients. Volumetric alterations of mesiotemporal brain structures have been reported in the specific spatial and temporal patterns of expression in embryos. Binding of the NCAM molecules on the cell hippocampal formation, amygdala, and entorhinal region. 1, 2 Abnormalities in neuronal orientation and surface is regulated by the type and number of immunoglobulin domains and also by the presence of altered neural cell sizes have also been described in limbic regions and the frontal cortex. [3] [4] [5] The observed bound polysialic acid (PSA). PSA-NCAM is present in high concentrations at late embryonic stages, but the anomalies are present in regions implicated in the symptomatology of schizophrenia, and are suggestive PSA decreases during development, resulting in higher adhesion properties for NCAM. In the adult, polysialylof disturbed neurodevelopmental mechanisms such as neural cell differentiation or migration. Molecules ated forms of NCAM are restricted to areas of the CNS that retain plasticity and neurogenesis, such as the involved in these mechanisms are candidate etiological factors for schizophrenia, not only for their role in neuolfactory bulb, the hippocampus and the cerebellum. 13, 14 Besides its role in neurodevelopment, NCAM rodevelopment, but also because they are often also involved in cognitive functions, such as learning and has important functions in the mature CNS, being involved in plasticity mechanisms underlying memory memory, that are impaired in schizophrenia patients. 6, 7 A number of molecular studies have reported alterand learning, such as LTP. 15 Gene-targeted mice for the NCAM gene are healthy and fertile, but have brain morations of neurodevelopmental molecules in schizophrenia: the neural cell adhesion molecule (NCAM), phology alterations in the olfactory bulb, hippocampus and cerebellum, and show deficits in spatial learnsynapsin, synaptophysin, and glutamate receptors have been shown to be altered in temporal lobe structures ing. 16, 17 The alterations reported in the NCAM-deficient animals evidence the involvement of this cell adhesion and frontal cortex of schizophrenia patients. [8] [9] [10] [11] NCAM is a cell-surface receptor that mediates homomolecule not only in the development of specific brain regions required for adult cognitive functions but also philic adhesion between neural cells and plays a role in the continued performance of some of these functions.
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The importance of the NCAM molecule in neurodev- association tests that do not require genetic model was later isolated, using the same probe, and used for specification, and allow the detection of a suscepti-HRR association analysis in the nuclear families. bility locus, which may not be sufficient or necessary Amplification conditions for polymorphism 1, used for disease expression but significantly increases the in the linkage analysis sample, were adapted from Telrisk of disease. The HRR design, using the parent's atar et al, 21 as follows: 50 ng of template DNA were untransmitted alleles as the control haplotype, circumamplified in a final volume of 12.5 l containing vents the problems of population stratification that are 12. 72°C. The products were resolved in an 8% polyacryla-14 (2.8 per family on average) were diagnosed with mide gel and visualized by autoradiography. In this broader spectrum of disorder, including psychosis, sample, the polymorphism reveals a 7-allele system, schizoid personality disorder, schizotypal personality with the following allele frequencies (from the disorder or paranoid personality disorder. DNA parents): A1 = 0.025, A2 = 0.016, A3 = 0.117, samples were available for 91 members in these famil-A4 = 0.440, A5 = 0.301, A6 = 0.085, and A7 = 0.016. ies. The brain structure of 42 individuals from these families was studied with computerized tomography. 2 Temporal lobe abnormalities were observed in psyStatistical analysis Linkage analysis in the five multiplex families was perchotic individuals compared to unaffected family members, suggesting an association between schizoformed using the MLINK program of the LINKAGE program package (version 5.1). Parameters for the genetic phrenia and a familial genetic factor causing the brain structural alterations, possibly of developmental linkage model were: autosomal inheritance (dominant and recessive models); disease gene frequency 0.0085 origin.
Association analysis was conducted in a sample of and 0.15 for dominant and recessive models, respectively; 70% penetrance; phenocopies 0.001; and the seventy-one nuclear families with one affected offspring. The families were recruited from patients at the broad diagnosis category was used (schizophrenia, schizoaffective disorder, atypical psychosis, schizo- between marker and disease locus, = 1/2 meaning no linkage between marker and disease) by applying a McNemar's 2 test. TDT was performed using the Genetic Analysis System (GAS) program, version 1.4 (Alan NCAM gene is unlikely to be involved in schizophrenia in our sample. Young, Oxford University).
Results Discussion
We have used two genetic strategies for the evaluation Using a dual genetic approach of linkage analysis in five informative families and association studies in an of the role of the NCAM gene in schizophrenia. This region includes other candidate genes such as the HRR sample, we have found no evidence for linkage or association of the candidate gene NCAM to schizodopamine D2 receptor (DRD2) and an apolipoprotein gene cluster; both these sites are tightly linked to the phrenia. Negative lod scores were obtained by linkage analysis in the five pedigrees studied under both the NCAM gene. 23, 24 The results corroborate a previous linkage analysis of DRD2 and schizophrenia excluding dominant model (LOD = −13.1 at = 0) and the recessive model (LOD = −10.6 at = 0). These lod scores the 11q23 region, 25 although linkage to this chromosomal region in a pedigree from Quebec has also been exclude linkage within 20 cM on either side of the NCAM locus that lies in the region of 11q23. Both reported. 26 The HRR analysis results obtained were consistent with our linkage analysis, yielding no evidominant and recessive models were used in order to cover the range of possible genetic models and allow dence for association or transmission disequilibrium of the NCAM locus and schizophrenia. for inaccuracies in parameter estimation.
Although the precise location of polymorphisms 1 Using this dual strategy, we considered the detection not only of major loci closely linked with schizoand 2 relative to each other and to the NCAM gene has not been reported, they were isolated with the same phrenia, but also of susceptibility loci, not segregating in Mendelian fashion in these families, that confer an cDNA probe from a cosmid library, and in all likelihood are located in very close proximity. It is therefore increased risk for the disease. We conclude that our results represent strong evidence against the involveprobably adequate to use polymorphism 2 as an equivalent marker in the genetic association strategy. The ment of a structural mutation in the NCAM gene in the etiology of schizophrenia. HRR strategy results revealed no evidence for association of this marker to schizophrenia (
The involvement of NCAM in schizophrenia is not, however, ruled out. The alterations observed for the P = 0.280, d.f. = 6, see Table 1 ). Similarly, TDT analysis yield non-significant P values (Table 2 ). It should be PSA form of NCAM in the brains of schizophrenics, 8 the role of the molecule in development, synaptic plasnoted that the allele count for the TDT analysis is lower than in the HRR analysis because parents who are ticity and cognitive functions, maintains it as an intriguing candidate gene. An additional relevant findhomozygous are not utilized in the TDT calculations. These results indicate that a structural mutation in the ing is a reported alteration of olfactory function in schizophrenics, 27 which is consistent with the NCAM deficiency leading to olfactory bulb alterations in gene- 33 In several other diseases genes have been sialylated NCAM in the dentate gyrus of the adult rat.
shown to be imprinted, and recently imprinting has 
